High night-to-night variability in obstructive sleep apnea (OSA) severity is associated with increased odds of nonfatal major ...

Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...

New research to be presented at this year’s European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that ...

People with obstructive sleep apnea often snore loudly, wake up frequently during the night, and feel very tired during the ...

People with obstructive sleep apnea have a 71% higher risk of cardiovascular events and death. Met Gala 2026 will celebrate ...

New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that those living with obstructive sleep apnea (OSA) have a 71% higher risk of ...

New research to be presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that those ...

This FR proposes the introduction of a generic, event‑driven webhook system in CPAP‑AutoSync. The goal is to allow users to integrate CPAP‑AutoSync with external automation, monitoring, and ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

Obstructive sleep apnea (OSA) is a common sleep disorder and one of the common causes of secondary hypertension. Patients with this condition often have characteristics such as reverse spoon-shaped ...

In the Phase 2 FLOW study for the treatment of OSA, sulthiame met the primary endpoint across all doses, and significantly improved multiple efficacy measures, while demonstrating a favorable safety ...